These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 9532188)

  • 1. No correlation between in vitro and in vivo function of human islets.
    Gerling IC; Kotb M; Fraga D; Sabek O; Gaber AO
    Transplant Proc; 1998 Mar; 30(2):587-8. PubMed ID: 9532188
    [No Abstract]   [Full Text] [Related]  

  • 2. Xenotransplantation of islets of Langerhans in diabetes mellitus.
    Mandel TE; Koulmanda M
    Transplant Proc; 1994 Jun; 26(3):1110-2. PubMed ID: 8029849
    [No Abstract]   [Full Text] [Related]  

  • 3. NOD mouse peritoneal cellular response to poly-L-lysine-alginate microencapsulated rat islets.
    Weber C; Ayres-Price J; Costanzo M; Becker A; Stall A
    Transplant Proc; 1994 Jun; 26(3):1116-9. PubMed ID: 8029851
    [No Abstract]   [Full Text] [Related]  

  • 4. Leflunomide and its analogue X920715 synergize with cyclosporin A in preventing early graft failure and delaying graft rejection of xenogeneic islets in nonobese diabetic mice.
    Gysemans C; Waer M; Laureys J; Bouillon R; Mathieu C
    Transplant Proc; 2001 May; 33(3):2094-5. PubMed ID: 11377464
    [No Abstract]   [Full Text] [Related]  

  • 5. Early graft failure of xenogeneic islets in NOD mice is accompanied by high levels of interleukin-1 and low levels of transforming growth factor-beta mRNA in the grafts.
    Gysemans CA; Waer M; Valckx D; Laureys JM; Mihkalsky D; Bouillon R; Mathieu C
    Diabetes; 2000 Dec; 49(12):1992-7. PubMed ID: 11117999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transplantation of microencapsulated syngeneic and xenogeneic (neonatal porcine) islets in nonobese diabetic mice.
    Ao Z; Suarez-Pinzon WL; Rajotte RV; Korbutt GS; Flashner M; Rabinovitch A
    Transplant Proc; 1998 Mar; 30(2):500. PubMed ID: 9532147
    [No Abstract]   [Full Text] [Related]  

  • 7. Successful discordant pancreatic islet xenotransplantation by prevention of primary nonfunction graft rejection and autoimmune disease recurrence.
    Henretta J; Pittman K; McFadden T; Thomas F
    Transplant Proc; 1994 Jun; 26(3):1133-4. PubMed ID: 8029859
    [No Abstract]   [Full Text] [Related]  

  • 8. Encapsulated islet iso-, allo-, and xenografts in diabetic NOD mice.
    Weber CJ; Hagler M; Konieczny B; Chryssochoos J; Rajotte R; Lakkis F; Lowry R
    Transplant Proc; 1995 Dec; 27(6):3308-11. PubMed ID: 8539965
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of FK 506 on islet allograft rejection in mice and pigs.
    Nagata M; Yamaguchi T; Stein E; Mullen Y; Ochiai T
    Transplant Proc; 1991 Dec; 23(6):3213-6. PubMed ID: 1750090
    [No Abstract]   [Full Text] [Related]  

  • 10. Islet and pancreatic transplantation--autoimmunity and alloimmunity.
    Eisenbarth GS; Stegall M
    N Engl J Med; 1996 Sep; 335(12):888-90. PubMed ID: 8778611
    [No Abstract]   [Full Text] [Related]  

  • 11. Differential effect of leflunomide on concordant xenogeneic islet graft rejection and recurrence of autoimmune diabetes.
    Guo Z; Mital D; Shen J; Chong AS; Tian Y; Foster P; Sankary H; McChesney L; Jensik SC; Williams JW
    Transplant Proc; 1998 Mar; 30(2):463-4. PubMed ID: 9532129
    [No Abstract]   [Full Text] [Related]  

  • 12. The syngeneic islet transplantation to study physiology and pathophysiology of pancreatic beta-cells.
    Hahn HJ; Kuttler B
    Adv Exp Med Biol; 1997; 426():411-9. PubMed ID: 9544301
    [No Abstract]   [Full Text] [Related]  

  • 13. Encapsulated piscine (tilapia) islets for diabetes therapy: studies in diabetic NOD and NOD-SCID mice.
    Safley SA; Cui H; Cauffiel SM; Xu BY; Wright JR; Weber CJ
    Xenotransplantation; 2014; 21(2):127-39. PubMed ID: 24635017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Humoral reaction to microencapsulated rat, canine, and porcine islet xenografts in spontaneously diabetic NOD mice.
    Weber C; D'Agati V; Ward L; Costanzo M; Rajotte R; Reemtsma K
    Transplant Proc; 1993 Feb; 25(1 Pt 1):462-3. PubMed ID: 8438379
    [No Abstract]   [Full Text] [Related]  

  • 15. Approaches to the prevention of immune destruction of transplanted pancreatic islets.
    Lafferty KJ; Hao L
    Transplant Proc; 1994 Apr; 26(2):399-400. PubMed ID: 8171476
    [No Abstract]   [Full Text] [Related]  

  • 16. Prolonged reversal of diabetic state in NOD mice by xenografts of microencapsulated rat islets.
    Lum ZP; Tai IT; Krestow M; Norton J; Vacek I; Sun AM
    Diabetes; 1991 Nov; 40(11):1511-6. PubMed ID: 1936609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of cytokines during rejection of fetal pig islet xenografts in nonobese diabetic mice.
    Kovarik J; Faulkner-Jones BE; Koulmanda M; Mandel TE
    Transplant Proc; 1996 Apr; 28(2):811. PubMed ID: 8623411
    [No Abstract]   [Full Text] [Related]  

  • 18. In vivo imaging of immune rejection in transplanted pancreatic islets.
    Evgenov NV; Medarova Z; Pratt J; Pantazopoulos P; Leyting S; Bonner-Weir S; Moore A
    Diabetes; 2006 Sep; 55(9):2419-28. PubMed ID: 16936189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Xenotransplantation of islets of Langerhans: a possible therapy for diabetes mellitus?].
    Igaz P
    Wien Med Wochenschr; 2001; 151(13-14):291-4. PubMed ID: 11582992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rejection of human islets and human HLA-A2.1 transgenic mouse islets by alloreactive human lymphocytes in immunodeficient NOD-scid and NOD-Rag1(null)Prf1(null) mice.
    Banuelos SJ; Shultz LD; Greiner DL; Burzenski LM; Gott B; Lyons BL; Rossini AA; Appel MC
    Clin Immunol; 2004 Sep; 112(3):273-83. PubMed ID: 15308121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.